Héctor Parra-Riffo, Juan Lemus-Peñaloza. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » AgedAnti-Bacterial Agents/adverse effectsAnti-Bacterial Agents/therapeutic useCatheter-Related Infections/drug therapyCatheter-Related Infections/etiologyDrug Therapy, CombinationEnterococcusGram-Negative Bacterial Infections/drug therapyGram-Negative Bacterial Infections/etiologyGram-Negative Bacterial Infections/microbiologyGram-Positive Bacterial Infections/drug therapyGram-Positive Bacterial Infections/etiologyGram-Positive Bacterial Infections/microbiologyHumansHypoglycemia/chemically inducedImmunocompromised HostKidney Failure, Chronic/complicationsKidney Failure, Chronic/therapyLevofloxacinMaleOfloxacin/adverse effectsOfloxacin/therapeutic useRenal DialysisSepsis/drug therapySepsis/etiologySepsis/microbiologyStenotrophomonas maltophiliaTrimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
Substances： See more » Anti-Bacterial AgentsLevofloxacinTrimethoprim, Sulfamethoxazole Drug CombinationOfloxacin
Year: 2012 PMID： 22806298 DOI： 10.3265/Nefrologia.pre2012.Feb.11248
Source DB: PubMed Journal: Nefrologia ISSN： 0211-6995 Impact factor: 2.033